Abstract
Desglycinyl remacemide (DGR), a biologically active metabolite of remacemide, was radiolabeled in an attempt to develop a ligand binding assay to identify its site of action. Incubation of the radioligand with membranes obtained from P2 fractions of whole rat brain revealed a single population of specific [3H]-DGR binding sites having a K(d) of 290 nM and a B(max) of 1.3 pmole/mg protein. The specific binding of [3H]-DGR is most enriched in the P2 subcellular fraction and is heterogeneously distributed throughout the brain. The binding of [3H]-DGR to rat brain membranes was inhibited most potently by MK-801 and SKF-10,047. In contrast, haloperidol, and other sigma receptor-active agents, were relatively inactive at this site. These data suggest that DGR interacts with a channel blocking site on the NMDA receptor.
Original language | English (US) |
---|---|
Pages (from-to) | 46-50 |
Number of pages | 5 |
Journal | Brain Research |
Volume | 827 |
Issue number | 1-2 |
DOIs | |
State | Published - May 8 1999 |
Externally published | Yes |
Keywords
- Anticonvulsant
- Desglycinyl remacemide
- MK- 801
- Phencyclidine
- Remacemide
- SKF-10,047
ASJC Scopus subject areas
- General Neuroscience
- Clinical Neurology
- Developmental Biology
- Molecular Biology